Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 12,554 | 11,041 | 13,905 | 23,289 | 34,263 |
| TOTAL | $13,622 | $12,618 | $14,893 | $24,250 | $35,899 |
| Non-Current Assets | |||||
| PPE Net | 595 | 648 | 701 | 757 | 910 |
| Other Non-Current Assets | 411 | 430 | 449 | 467 | 484 |
| TOTAL | $1,006 | $1,078 | $1,150 | $1,224 | $1,394 |
| Total Assets | $14,628 | $13,695 | $16,042 | $25,474 | $37,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,015 | 4,679 | 3,874 | 7,585 | 8,304 |
| Other current liabilities | 802 | 1,096 | 2,058 | 1,718 | 11,929 |
| TOTAL | $4,912 | $5,867 | $6,021 | $9,388 | $20,314 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,382 | 1,744 | 1,768 | 1,382 | 1,814 |
| TOTAL | $1,718 | $1,744 | $1,768 | $1,792 | $1,814 |
| Total Liabilities | $6,630 | $7,610 | $7,789 | $11,179 | $22,128 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,240 | 3,192 | 1,534 | 1,534 | 1,374 |
| Common Shares | 0 | 0 | 1 | 0 | 0 |
| Retained earnings | -263,838 | -259,394 | -253,947 | -247,343 | -244,987 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 4,369 |
| TOTAL | $7,997 | $6,085 | $8,253 | $14,295 | $15,165 |
| Total Liabilities And Equity | $14,628 | $13,695 | $16,042 | $25,474 | $37,293 |